Fund manager Greg Newman of Newman Group ScotiaMcLeod says he is “going out on a limb” by making Telus one of his top picks.

The biggest Liberation Day winner”. That’s where Citi analyst James Hardiman thinks BRP stands in the North American travel ...

Its fourth quarter results are in the books and Haywood analyst Neal Gilmer has maintained his “Buy” rating on Rubicon ...

What’s the latest on Donald Trump’s tariffs? You might want to check your watch, not your calendar say economists at RBC.

Following the company’s fourth quarter results, RBC analyst Paul Treiber has cut his price target on BlackBerry ...

Following the company’s most recent acquisition, Haywood analyst Neal Gilmer has maintained his “Buy” rating on Organigram.

Following the company’s fourth quarter results, National Bank Financial analyst Rupert Merer has downgraded Exro Technologies ...

Delayed financials from WELL Health mean an opportunity for investors, says Ventum Capital Markets analyst Rob Goff.

HEALWELL AI has made an acquisition that will present the company with immediate upsell opportunities., says Raymond James ...

TD Cowen analyst Vince Valentini says he is feeling more bullish about Quebecor, and has raised his price target on it.

Its fourth quarter results are in the books and Ventum Capital Markets analyst Andrew Semple thinks there is still good money ...

Following the company’s fourth quarter results, ATB Capital analyst Martin Toner has cut his price target on Bitfarms.